Solace Therapeutics
Kevin Connors has worked in various roles in the corporate world since 1992. Their first role was as President and CEO of Vesica Medical, Inc. in 1992. Kevin then joined Masimo Corporation as a Board Member in 1998, followed by Intrinsic Therapeutics as a Board Member in 1999. In 2000, they became a Board Member of CoTherix. In 2006, they joined Interlace Medical as a Board Member. From 2011 to 2014, they were the Executive Director and Founder of Solace Therapeutics, and in 2014 they became a Board Member of Sparx Hockey and the CEO of AgenDx Biosciences. Kevin is currently a General Partner at Spray Venture Partners.
Kevin Connors attended R. Nelson Snider High School before going on to pursue a Bachelor of Science in Electrical Engineering from the University of Notre Dame from 1979 to 1983. Kevin then went on to the University of Dayton to earn a Master of Science in Electrical Engineering from 1983 to 1985. Afterwards, they attended Harvard Business School to earn an MBA in Business from 1985 to 1987.
This person is not in any teams
This person is not in any offices
Solace Therapeutics
Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), Solace is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies.